Robert E. George
CIK: 0001674701
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MBRX
Moleculin Biotech, Inc.
Director
Discretionary Trading P&L
Holdings
About George Robert E.
George Robert E. (SEC CIK 0001674701) files insider reports with the SEC as Director of Moleculin Biotech, Inc. (MBRX).
Signal8 holds 2 ownership filings by George Robert E., all Form 4s, filed between Nov 6, 2024 and Nov 14, 2025. Those filings report 2 transactions, from Nov 4, 2024 to Nov 12, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on George Robert E.'s filings is in HOUSTON, TX.
Recent filings by George Robert E.
Other insiders filing for Moleculin Biotech, Inc. (MBRX)
- PICKER DONALD H, Chief Science Officer
- KLEMP WALTER V, CEO and President
- Foster Jonathan P., Chief Financial Officer
- Yan Joy, Director
- Cermak Elizabeth, Director
- CANNON MICHAEL D, Director